Management of Severe Renal Impairment (GFR 18 mL/min, Creatinine 2.79 mg/dL)
This patient requires urgent nephrology referral and preparation for renal replacement therapy (RRT), as they have Stage 5 chronic kidney disease with a GFR well below the critical threshold of 30 mL/min. 1
Immediate Nephrology Referral
- Refer immediately to nephrology for patients with GFR <30 mL/min, though this patient at GFR 18 mL/min is in Stage 5 CKD and requires urgent evaluation for RRT planning 1
- The risk of kidney failure requiring RRT within 1 year is extremely high at this level of renal function, warranting immediate specialist involvement 1
- This GFR level (10-20 mL/min range) represents severe renal insufficiency where many diagnostic and therapeutic interventions carry substantial risk 1
Critical Medication and Procedure Considerations
Contrast Agent Restrictions
- Avoid iodinated radiocontrast unless absolutely necessary for life-saving evaluation or intervention 1
- At GFR 10-20 mL/min, iodine-containing contrast should not be administered except in the context of urgent revascularization procedures 1
- If contrast is unavoidable, measure serum creatinine immediately post-procedure to institute necessary clinical care 1
- Consider alternative imaging with CO2 gas or gadolinium-based agents when feasible 1
Medication Dose Adjustments
Allopurinol dosing:
- Adjust maximum allopurinol dose according to creatinine clearance to prevent severe cutaneous adverse reactions (SCARs), which have 25-30% mortality 1
- At this GFR, consider switching to febuxostat or benzbromarone (though benzbromarone is contraindicated if eGFR <30 mL/min) 1
Anticoagulation considerations:
- Dabigatran is contraindicated (80% renal elimination) 1
- Edoxaban, rivaroxaban, and apixaban require dose reduction but can be used with caution (50%, 35%, and 27% renal elimination respectively) 1
- Monitor renal function at minimum every 2 months (calculated as GFR/10 = frequency in months) 1
Phosphate binders:
- Sevelamer can be used without dose adjustment as it is not systemically absorbed 2
Fluid and Volume Management
- Maintain euvolemia through careful diuretic management - patients at this stage often develop diuretic resistance requiring high-dose loop diuretics or combination therapy with metolazone 1
- If volume overload persists despite maximal medical therapy, consider ultrafiltration or hemofiltration 1
- Small to moderate elevations in BUN and creatinine during aggressive diuresis should not prompt therapy reduction unless renal dysfunction is severe or progressive 1
- Restrict dietary sodium to ≤2 g daily and consider fluid restriction to 2 liters daily if persistent volume overload 1
Prognostic Implications
- Elevated creatinine at this level is a potent independent risk factor for mortality - patients with creatinine ≥1.7 mg/dL have more than three times the mortality of those with lower values 3
- This patient's creatinine of 2.79 mg/dL places them at substantially elevated risk for cardiovascular events and death 1
- In cirrhotic patients specifically, creatinine >1.5 mg/dL (133 μmol/L) is a diagnostic criterion for hepatorenal syndrome and carries poor prognosis 1
RRT Planning
- Initiate RRT planning discussions immediately, including conservative management options 1
- At GFR 18 mL/min, the patient is approaching absolute indications for dialysis (typically GFR 10-15 mL/min or symptomatic uremia) 1
- Discuss vascular access creation for hemodialysis or peritoneal dialysis catheter placement 1
- Evaluate for kidney transplantation candidacy if appropriate 1
Monitoring Requirements
- Measure renal function at least monthly at this GFR level (GFR 18 ÷ 10 = every 1.8 months minimum) 1
- Monitor for uremic symptoms: nausea, vomiting, altered mental status, pericarditis, bleeding diathesis 1
- Check electrolytes frequently for hyperkalemia, metabolic acidosis, and hyperphosphatemia 1
- Monitor volume status closely for pulmonary edema risk 1
Common Pitfalls to Avoid
- Do not rely on serum creatinine alone - normal creatinine values can mask severe renal dysfunction, especially in elderly or low-weight patients 4, 5
- Avoid nephrotoxic medications including NSAIDs, aminoglycosides, and unnecessary contrast 1
- Do not delay nephrology referral - late referral (defined as <1 year before RRT initiation) worsens outcomes 1
- Recognize that intercurrent acute illnesses can transiently worsen renal function and require medication adjustments 1